Previous 10 | Next 10 |
Channelchek news releases related Channelchek news releases and Channelchek press releases from 06/20/21 12:00:00 on US and Canada Markets.
Game over, the smart money is now the self-directed investor. Individual Investors are continuing to stymie investment markets and make even more headway in their newfound leadership role. In the first half of this year, new investment accounts opened by self-directed investors have already eq...
Initial results from the Phase II Tyko drill program. A total of 14 holes representing 1,370 meters of drilling were completed, of which 11 intersected massive and/or semi-massive sulphide mineralization at the Smoke Lake Zone. The company has reported results for 6 of the 14 holes completed. ...
New Rigosertib Study Shows Mechanism Of Action A study published in the medical journal Molecular Cancer detailed how rigosertib's action through the RAS pathway could improve the response to checkpoint inhibitors. Rigosertib is currently in a Phase 1 clinical trial in combination with the PD-...
Friday, June 18, 2021 Energy Services of America (ESOA) PPP Loan Foregiveness Announced Energy Services of America Corporation is engaged in providing contracting se Read More >>
Beverly Hills, CA, June 17, 2021 (GLOBE NEWSWIRE) -- FAT (Fresh. Authentic. Tasty.) Brands Inc. (NASDAQ: FAT, FATBP, FATBW), a leading global franchising company and parent company of iconic brands including Fatburger, Johnny Rockets, and seven other restaurant concepts, today announced the pr...
Featuring Avalon GloboCare (AVCO), Caladrius Biosciences (CLBS), Celularity, ImmCelz / Creative Medical Technology Holdings (CELZ), ExoProTher, GID BIO, HealthLynked (HLYK), Longeveron (LGVN), Mesoblast (MESO) - Presented by Channelchek and Noble Capital Markets Read More >>
Featuring Avalon GloboCare (AVCO), Caladrius Biosciences (CLBS), Celularity, ImmCelz / Creative Medical Technology Holdings (CELZ), ExoProTher, GID BIO, HealthLynked (HLYK), Longeveron (LGVN), Mesoblast (MESO) - Presented by Channelchek and Noble Capital Markets Read More >>
Permanent CEO. Helius has named interim CEO and President Dane Andreeff as full-time CEO and President. Mr. Andreeff was appointed to the interim roles in August 2020. Since assuming the roles, Mr. Andreeff guided Helius to FDA approval of the PoNS treatment for MS in the U.S. and is positioni...
Avalon Globocare President & CEO Dr. David Jin and CFO Luisa Ingargiola - The Investor Forum at the World Stem Cell Summit. Each presentation features a formal corporate overview, followed by a Q & A session moderated by a Noble Capital Markets equity research representative. Read Mor...
Mesoblast CEO & Managing Director Dr Silviu Itescu - The Investor Forum at the World Stem Cell Summit. Each presentation features a formal corporate overview, followed by a Q & A session moderated by a Noble Capital Markets equity research representative. Read More >>
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
18.48%Change Percent:
Procore Technologies Inc. Company Name:
PCOR Stock Symbol:
NYSE Market:
procore.com Website: